We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1 mg/mL pump actuated metered dose aerosol (reformulation), GlaxoSmithKline Consumer Healthcare Australia Pty Ltd, CON-885
Product name
OTRIVIN ADULT NASAL SPRAY xylometazoline hydrochloride 1 mg/mL pump actuated metered dose aerosol (reformulation)
Sponsor name
GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
Consent start
Consent no.
CON-885
Duration
The consent is effective from 25 November 2021 until 26 November 2023.
Standard
Subparagraph 11(2)(f)(i) of Therapeutic Goods Order No. 92 - Standard for labels of non-prescription medicines (TGO 92)
Non-compliance with standard
The products do not conform to the requirements of subparagraph 11(2)(f)(i) of
Therapeutic Goods Order No. 92 Standard for labels of non-prescription medicines
(TGO 92) in that the medicine labels express the quantity of the active
ingredient as weight per volume instead of quantity delivered per actuation.
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Other therapeutic goods registered